Pharmacotherapy and Intensive Treatment of Drug Abuse - 1

This study has been completed.

First Received on September 20, 1999. Last Updated on June 23, 2005 History of Changes

Sponsor:	National Institute on Drug Abuse (NIDA)
Collaborator:	Department of Veterans Affairs
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000217

Purpose

The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.

Condition	Intervention	Phase
Cocaine-Related Disorders Substance-Related Disorders	Drug: Carbamazepine	Phase II

Study Type:	Interventional
Study Design:	Primary Purpose: Treatment
Official Title:	Pharmacotherapy and Intensive Treatment of Drug Abuse

Resource links provided by NLM:

MedlinePlus related topics: Anxiety Drug Abuse

Drug Information available for: Carbamazepine

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Drug use
Effectiveness of medication
Level of pharm
Retention
Depression, anxiety

Estimated Enrollment:

Eligibility

Ages Eligible for Study:	18 Years to 60 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000217

Locations

United States, Missouri
University of Kansas
Kansas City, Missouri, United States, 64128

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

Department of Veterans Affairs

Investigators

Principal Investigator:

William Haning, M.D.

University of Kansas

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00000217 History of Changes
Other Study ID Numbers:	NIDA-06954-1, R18-06954-1
Study First Received:	September 20, 1999
Last Updated:	June 23, 2005
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Substance-Related Disorders
Cocaine-Related Disorders
Mental Disorders
Carbamazepine
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs

Pharmacologic Actions
Central Nervous System Agents
Therapeutic Uses
Anticonvulsants
Antimanic Agents
Tranquilizing Agents
Central Nervous System Depressants
Psychotropic Drugs

ClinicalTrials.gov processed this record on February 09, 2012